Shinpoong Pharmaceutical Co (XKRX:019170) Interest Expense : ₩-2,270 Mil (TTM As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Shinpoong Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shinpoong Pharmaceutical Co's interest expense for the three months ended in Mar. 2024 was ₩ -660 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-2,270 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shinpoong Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was ₩ -3,461 Mil. Shinpoong Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ₩ -660 Mil. Shinpoong Pharmaceutical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shinpoong Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Shinpoong Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shinpoong Pharmaceutical Co Interest Expense Chart

Shinpoong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-4,114.72

-2,944.83

-202.06

-61.42

-1,718.66

Shinpoong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-108.30	-471.34	-472.45	-666.58	-659.75

Shinpoong Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,270 Mil.

Shinpoong Pharmaceutical Co (XKRX:019170) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shinpoong Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ₩-660 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩-3,461 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩189 Mil.

Shinpoong Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Shinpoong Pharmaceutical Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Shinpoong Pharmaceutical Co (XKRX:019170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shinpoong Pharmaceutical Co Ltd (XKRX:019170) » Definitions » Interest Expense

Traded in Other Exchanges

019175:Korea

Address

161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246

Website

https://shinpoong.co.kr

Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.

Shinpoong Pharmaceutical Co (XKRX:019170) Headlines

No Headlines